Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
April 18, 2024 07:30 ET
|
Benitec Biopharma Inc.
-First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients worldwide- - BB-301 facilitated improvements...
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
April 18, 2024 07:00 ET
|
Benitec Biopharma Inc.
HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
UPDATE: Predicine Introduces PredicineCARE™ NGS Kit for Tumor Profiling
April 11, 2024 23:07 ET
|
Predicine
Predicine’s Decentralized Lab Testing Solution Facilitates Clinical Trials, Companion Diagnostics (CDx) Development, and Patient Testing on a Global Scale.
Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024
April 09, 2024 08:00 ET
|
Benitec Biopharma Inc.
HAYWARD, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
Predicine Announces Collaboration with Apollomics to Develop PredicineCARE™ as a Companion Diagnostic Assay in Lung Cancer
April 05, 2024 16:21 ET
|
Predicine
Collaboration Utilizing PredicineCARE™ Blood cfDNA NGS Assay Marks Progress in Employing Comprehensive Genomic Profiling for Detection of Select Alteration
Predicine Introduces PredicineCARE™ NGS Kit for Global Clinical Trials, CDx Development and Patient Testing
April 05, 2024 16:10 ET
|
Predicine
Predicine’s Decentralized Lab Testing Solution Facilitates Clinical Trials, Companion Diagnostics (CDx) Development, and Patient Testing on a Global Scale.
Predicine to Present 15 Liquid Biopsy Studies at AACR 2024
April 05, 2024 02:08 ET
|
Predicine
HAYWARD, Calif., April 05, 2024 (GLOBE NEWSWIRE) -- Predicine, Inc. A leading precision oncology company, announced today that it will present data from 15 ctDNA studies at AACR 2024, spotlighting...
North America Courier Express and Parcel Market Poised for Growth, Aided by Technology Advancements in Automation
March 22, 2024 18:18 ET
|
Research and Markets
Dublin, March 22, 2024 (GLOBE NEWSWIRE) -- The "North America Courier Express and Parcel Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Business...
La Rosa Acquires Real Estate Brokerage Franchisee in California
March 20, 2024 08:00 ET
|
La Rosa Holdings Corp.
Launching La Rosa’s multi-level revenue share plan in California intended to empower realtors with a unique income stream Ninth franchisee that has been acquired since IPO Reaffirms target to...
Clarus Reports Fourth Quarter and Full Year 2023 Results
March 07, 2024 16:15 ET
|
Clarus Corporation
Adventure Segment Generates Highest Quarterly Revenue of the Year Proceeds from Precision Sport Sale Used to Repay All Debt and Significantly Increased Cash Position ...